Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Dabigatran results encourage phase III investigation in atrial fibrillation patients

Sep. 15, 2005

Studies confirm that prasugrel is effective in inhibiting platelet aggregation

Sep. 13, 2005

Novel agents for thrombotic disorders imparted by Daiichi

Sep. 13, 2005

BMS-740808: A novel factor Xa inhibitor with in vivo efficacy and good PK profile

Sep. 12, 2005

In vivo models validate superior efficacy of BAY-59-7939 over fondaparinux

Sep. 9, 2005

ACTIVE W arm discontinued in clopidogrel program

Sep. 9, 2005

Phase III program begins for alfimeprase in central venous catheter occlusion

Sep. 8, 2005

Recent patents report novel agents for thrombotic disorders

Sep. 7, 2005

Pharming's recombinant human fibrinogen selected for U.S. Army project

Sep. 7, 2005

Phase I trial results of alfimeprase in peripheral arterial occlusion reported

Sep. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...